Ventyx Biosciences Inc (VTYX)

Apr 1, 2025, 7:00 AM EDT - 3 days ago

Ventyx Biosciences Expands SAB with Renowned NLRP3 Experts and Prominent Neurodegenerative and Cardiometabolic Disease Specialists

Feb 27, 2025, 4:05 PM EST - 5 weeks ago

Ventyx Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Corporate Progress

Feb 18, 2025, 8:00 AM EST - 6 weeks ago

Ventyx Biosciences Announces Presentation of Data from the Phase 2 Trial of Allosteric TYK2 Inhibitor VTX958 in Crohn's Disease at ECCO 2025

Feb 5, 2025, 8:00 AM EST - 2 months ago

Ventyx Biosciences to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Jan 14, 2025, 8:00 AM EST - 2 months ago

Ventyx Biosciences Highlights 2025 Pipeline Strategy and Provides Clinical Updates on its NLRP3 Inhibitor Portfolio

Nov 12, 2024, 7:30 AM EST - 5 months ago

Ventyx Biosciences to Participate in Three Upcoming Investor Conferences

Nov 4, 2024, 10:32 AM EST - 5 months ago

Ventyx Biosciences: Ready To Escape "The Crash Cycle"

Sep 23, 2024, 11:13 AM EDT - 6 months ago

Sanofi Injects $27M In Neurology Drug Developer Ventyx Biosciences

SNY

Sep 6, 2024, 8:00 AM EDT - 7 months ago

Ventyx Biosciences Announces Initiation of Dosing in a Phase 2a Trial of VTX3232 in Patients with Early Parkinson's Disease

Aug 30, 2024, 8:00 AM EDT - 7 months ago

Ventyx Biosciences Announces Departure of Chief Financial Officer

Aug 28, 2024, 8:00 AM EDT - 7 months ago

Ventyx Biosciences to Participate in Two Upcoming Investor Conferences

Aug 8, 2024, 4:01 PM EDT - 8 months ago

Ventyx Biosciences Reports Second Quarter 2024 Financial Results and Highlights Recent Corporate Progress

Jul 29, 2024, 2:31 PM EDT - 8 months ago

Dow Edges Lower; Ventyx Biosciences Shares Plummet

Jul 29, 2024, 11:03 AM EDT - 8 months ago

Ventyx Biosciences' Inflammatory Bowel Disease Candidate Flunks In Mid-Stage Study, Company Looks For Partner To Pursue It Further

Jun 24, 2024, 6:00 AM EDT - 10 months ago

VENTYX INVESTOR UPDATE: Ventyx's (Nasdaq:VTYX) Board is Being Investigated for Insider Trading, Long-term Investors Are Urged to Contact the Firm for Details

Jun 21, 2024, 4:15 PM EDT - 10 months ago

VENTYX INVESTOR NOTICE: Ventyx's (NASDAQ:VTYX) Board is Being Investigated for Insider Trading Allegations, Long-term Investors Are Urged to Contact the Firm for Details

Jun 20, 2024, 7:20 AM EDT - 10 months ago

VENTYX INVESTOR REMINDER: Ventyx (Nasdaq:VTYX) Shareholders are Urged to Contact BFA Law about its Review of the Board's Insider Trading Scheme

Jun 19, 2024, 4:20 PM EDT - 10 months ago

VENTYX INVESTIGATION REMINDER: Ventyx (Nasdaq:VTYX) Investors are Urged to Contact BFA Law about Inquiry into the Board for its Insider Trading Scheme and Avoiding Losses

Jun 18, 2024, 3:42 PM EDT - 10 months ago

VENTYX INSIDER TRADING INQUIRY: Ventyx (VTYX) Shareholders are Urged to Contact BFA Law about Investigation into the Board for Insider Trading Scheme and Avoiding Losses

Jun 17, 2024, 6:32 AM EDT - 10 months ago

VENTYX NOTIFICATION: Ventyx (VTYX) Shareholders are Encouraged to Contact BFA Law about Investigation into the Board for Insider Trading Scheme and Avoiding Substantial Losses

Jun 13, 2024, 4:06 PM EDT - 10 months ago

BFA Law Notice: Ventyx (Nasdaq: VTYX) Shareholders are Encouraged to Contact the Firm about Investigation into the Board for Insider Trading Scheme and Avoiding Substantial Losses

Jun 13, 2024, 7:13 AM EDT - 10 months ago

VENTYX REMINDER: BFA Law is Investigating Ventyx (Nasdaq: VTYX) Directors for Insider Trading Scheme and Avoiding Substantial Losses, Shareholders are Urged to Contact the Firm

Jun 12, 2024, 4:04 PM EDT - 10 months ago

STOCK DROP NOTICE: Ventyx (Nasdaq:VTYX) Stock Drops 20%, Investors are Encouraged to Contact BFA Law about the Investigation into the Company's Board for Insider Trading

Jun 11, 2024, 3:37 PM EDT - 10 months ago

VENTYX STOCK NOTICE: Ventyx (Nasdaq:VTYX) Stock Drops 20%, Shareholders are Reminded to Contact BFA Law about the Investigation into the Company's Board of Directors

Jun 11, 2024, 6:41 AM EDT - 10 months ago

VENTYX INVESTIGATION ANNOUNCEMENT: Ventyx (Nasdaq: VTYX) Stock Drops 20%, Investors are Urged to Contact BFA Law about the Investigation into the Company's Board

Jun 8, 2024, 5:24 AM EDT - 10 months ago

VENTYX NEWS NOTICE: Ventyx (Nasdaq: VTYX) Shareholders are Urged to Contact BFA Law about the Investigation into the Company's Board of Directors

Jun 5, 2024, 4:01 PM EDT - 10 months ago

Ventyx Biosciences Announces Positive Preclinical Data for CNS-Penetrant NLRP3 Inhibitor VTX3232 Demonstrating Reversal of Obesity and Improvements in Cardiometabolic and Inflammatory Markers

May 16, 2024, 8:00 AM EDT - 11 months ago

Ventyx Biosciences Announces Appointment of Matthew Moore as Chief Operating Officer

May 11, 2024, 1:58 PM EDT - 11 months ago

Ventyx Biosciences, Inc. (VTYX) Q1 2024 Earnings Call Transcript

May 2, 2024, 4:05 PM EDT - 1 year ago

Ventyx Biosciences to Report First Quarter 2024 Financial Results on May 9, 2024

Apr 30, 2024, 8:00 AM EDT - 1 year ago

FINAL DEADLINE IMMINENT: The Schall Law Firm Encourages Investors in Ventyx Biosciences, Inc. with Losses to Contact the Firm

Apr 28, 2024, 7:00 PM EDT - 1 year ago

FINAL DEADLINE TUESDAY: The Schall Law Firm Encourages Investors in Ventyx Biosciences, Inc. with Losses to Contact the Firm

Apr 28, 2024, 1:00 PM EDT - 1 year ago

FINAL DEADLINE IMMINENT: The Schall Law Firm Encourages Investors in Ventyx Biosciences, Inc. with Losses of $100,000 to Contact the Firm